The oxidative modification of low-density lipoprotein (LDL) can be induced by various active species by different mechanisms. Vitamin E and other radical-scavenging antioxidants can inhibit the free radicalmediated oxidation of LDL, but they are not effective against LDL oxidation induced by non-radical mechanisms.
Introduction
The hypothesis that the oxidative modification of low-density lipoprotein (LDL) plays a pivotal role in the progression of atherosclerosis has been widely accepted [1] . This prevalent oxidation hypothesis implies that the antioxidants which inhibit oxidation of LDL should be effective for suppressing atherosclerosis. In fact, the results of numerous in vitro and in vivo studies support the involvement of LDL oxidation in the pathogenesis of atherosclerosis and also the beneficial effects of antioxidants. On the other hand, however, largescale, double-blind intervention studies have not always shown consistent efficacy of antioxidants against atherosclerosis [2] , and some animal experiments have shown few or, under certain cases, even negative effects [3] . These inconsistent results have cast doubts on the oxidation hypothesis [4] .
However, such an inconsistent results may not be surprising, since the LDL oxidation must be induced by several oxidants and proceed by several mechanisms, and the efficacy of antioxidants may well depend on the type of oxidants and mechanisms. It means that particular antioxidants may be effective against some cases, but not for others. For example, vitamin E, the major antioxidant in LDL particles, exerts a potent antioxidant effect against free-radical-mediated oxidation of LDL, but it is not capable of inhibiting LDL oxidation mediated by non-radical mechanisms. Thus it is quite possible that vitamin E is not able to exert a beneficial effect on atherosclerosis induced by non-radical oxidation. It is important to evaluate antioxidant potency in relation to the type of oxidants and mechanisms. oxidants may be derived from exogenous sources, such as foods and smoking. The oxidants, oxidation mechanisms and specific markers are summarized in Table 1 . In many cases, polyunsaturated lipids are the primary target. Free-radicalmediated lipid peroxidation proceeds by a chain mechanism, where the lipid peroxyl radicals act as chain-carrying species. The mechanism and products of free-radical-mediated lipid peroxidation are independent of the initiating species, since the chain propagation is mediated by lipid peroxyl radicals, regardless of whether the oxidation is initiated by attack of hydroxyl radical, peroxynitrite, tyrosyl radical or other radical species. The reactivities of lipids towards peroxyl radicals increase with increasing numbers of double bonds, and arachidonates are approximately three times as reactive as linoleate. However, considering the concentrations in LDL particles, linoleates are the major substrates, whose oxidation proceeds by a straightforward mechanism to give racemic 9-and 13-hydroperoxyoctadecadienoates (HPODEs) in equal amounts. Both Z,E and E,E stereoisomers are formed.
On the other hand, the oxidation by 15-lipoxygenase proceeds by a non-radical mechanism and gives regio-, stereoand enantio-specific lipid hydroperoxides [5] . It has been shown that the oxidation of LDL and human plasma by mammalian 15-lipoxygenase gives 13(S)-9Z,11E-HPODE selectively [6] .
Myeloperoxidase (MPO) secreted from phagocytes has been implicated in the pathogenesis of atherosclerosis [7] . MPO uses hydrogen peroxide and halide ions to give hypochlorous (HOCl) or hypobromous (HOBr) acids and tyrosyl radical. They are potent oxidants and oxidize LDL by several mechanisms. The tyrosyl radical promotes lipid peroxidation in LDL and cross-links protein tyrosine residues into O,Odityrosine [8] . 3-Chlorotyrosine, a specific marker of MPOcatalysed oxidation, has been found to be markedly elevated in LDL isolated from human atherosclerotic intima [9] . HOCl reacts with hydrogen peroxide and hydroperoxide to give singlet oxygen and alkoxyl/peroxyl radicals respectively, but it reacts more rapidly with thiol and amino groups of proteins [10] , to give thiyl-and nitrogen-centred radicals [11] . HOCl reacts with amino groups to give also chloramines, which may break down to give aldehydes. Thus it should be noted that oxidation by MPO proceeds by both radical and non-radical mechanisms. Reactive nitrogen species are another species which may contribute in atherosclerosis. Nitric oxide (NO) is not a strong oxidant in itself, but it reacts rapidly with superoxide to give peroxynitrite, which oxidizes LDL to an atherogenic form [12] . At the same time, NO is known to act as a radicalscavenging antioxidant [13] .
The oxidative modification of apolipoprotein B-100 (apoB) may be more important than lipid oxidation for recognition by scavenger receptors on macrophages. The apoB may also be oxidized by both radical and non-radical mechanisms. The modifications of apoB by aldehydes formed by lipid peroxidation, glycation and amino acid oxidation may play an important role [14] .
The oxidized LDL is recognized by scavenger receptors and taken up by macrophages, which eventually leads to massive cholesterol loading and foam-cell formation. Furthermore, the oxidized LDL exerts various pro-atherogenic activities; that is, it can attract monocytes, induce monocyte adhesion to the endothelium, injure endothelium cells, induce migration and proliferation of smooth muscle cells, interfere with endothelium-mediated relaxation, and promote procoagulant properties of vascular cells [15] . Thus the inhibition of LDL oxidation is quite important for suppression of these actions, as well as uptake by macrophages.
Inhibition of LDL oxidation by antioxidants
As described above, LDL may be oxidatively modified by various pathways and the antioxidants may inhibit the oxidation at different steps (Scheme 1). In fact, we are protected against oxidative stress by an efficient defence network composed of various antioxidants with different functions. Superoxide dismutase quenches superoxide, which results in inhibition of the formation of peroxynitrite and reduction of transition-metal ions. Catalase reduces hydrogen peroxide formed by dismutation of superoxide. Glutathione peroxidases and selenoproteins reduce lipid hydroperoxides to the corresponding alcohols. Lipid hydroperoxides are a prerequisite for radical formation by metal ions and HOCl and also activation of lipoxygenase. Therefore the reduction of lipid hydroperoxides is effective for inhibiting LDL oxidation by iron or copper, lipoxygenase and HOCl. Proteins such as transferrin and ceruloplasmin sequester redoxactive iron and copper.
The role of radical-scavenging antioxidants has received much attention. Above all, vitamins E and C are the most abundant and reactive lipophilic and hydrophilic radicalscavenging antioxidant respectively. Other natural phenolic antioxidants contained in vegetables, fruits and beverages may also be effective. Anti-atherogenic drugs have been also developed. The capacity of these compounds as an antioxidant has been assessed extensively by various methods under different conditions. The 'antioxidant activity' is often determined by the method and condition employed, and great care should be taken in interpreting the data [16] . A few examples are shown below.
A simple model system is often employed in order to reveal the activity and action of an antioxidant. Stocker and colleagues [17] discovered that, in certain cases, vitamin E acts as a pro-oxidant by phase-and chain-transfer mechanisms in the oxidation of LDL. This is true, however, only in the oxidation of isolated LDL under specific reaction conditions. The prooxidant effect of vitamin E is not observed in the presence of vitamin C. A potent radical-scavenging antioxidant, such as vitamin E or C, often acts as a reductant and reduces Fe(III) and Cu(II) to Fe(II) and Cu(I) respectively. The transitionmetal ions at a lower valency state decompose hydroperoxides more rapidly to give alkoxyl radicals, and hence the antioxidants may act as a pro-oxidant in the presence of metal ions. However, the metal ions sequestered by proteins are not reduced by the antioxidant. Thus vitamins E and C may easily act as pro-oxidants in vitro, but it is doubtful if they act as pro-oxidants in vivo.
One of the difficult issues is the effect of species on the action of antioxidants. Probucol is used as an anti-atherogenic drug, and has been observed to be effective for rabbits, but not for mice [3] . Furthermore, the metabolites of probucol have been found to be dependent on species. Diphenoquinone (3,3 ,5,5 -tetra-t-butyl-4,4 -diphenoquinone), bisphenol (3,3 ,5,5 -tetra-t-butylbisphenol) and their precursor spiroquinone have been found in serum from probucoltreated rabbits and mice [18] . We have also analysed the metabolites in LDL of Watanabe heritable hyperlipidaemic (WHHL) rabbits fed on a probucol-containing diet (1% of food, w/w) and observed the concentrations of probucol, bisphenol and diphenoquinone of 14.5 ± 1.9, 7.1 ± 0.1 and 1.2 ± 0.1 mol/mol LDL (n = 4) respectively. On the other hand, little bisphenol and diphenoquinone were detected from LDL of hypercholesterolaemia patients who were administered 500 mg/day probucol for more than 2 months, although LDL contained 6.1 ± 2.0 mol of probucol/LDL (n = 12) [19] . Bisphenol acts as an antioxidant, but it is doubtful if it plays an important role in humans.
Non-antioxidant function of antioxidants
There is now emerging evidence which shows that phenolic antioxidants possess functions of gene regulation and signal transduction [20] . Such a function that is not related to antioxidant function may have beneficial effects against atherosclerosis. For example, α-tocopherol has been found to have anti-atherogenic effects, such as inhibition of monocyte-endothelial adhesion, inhibition of cytokine release, inhibition of platelet adhesion and aggregation, and inhibition of scavenger receptor expression [21, 22] . Such anti-atherogenic functions, which are independent of radical-scavenging action, have received much attention recently, but their physiological significance is a subject of future studies. The genomic and proteomic studies render novel insights into the molecular mechanisms of the anti-atherogenic properties of antioxidants [3] . For example, it has been shown by DNAmicroarray analysis studies that anti-atherogenic antioxidants down-regulated the genes of three subunits of proteasome: PSMA-2, -3 and -4 [23] .
Anti-atherogenic drugs
It is another question and challenge to develop an anti-atherogenic drug which surpasses the natural antioxidants. Probucol is an example, although it unfortunately exerts a side-effect of lowering HDL (high-density lipoprotein). Its mono-ester of butyric acid, AGI-1067, has been tested as a multifunctional anti-atherogenic drug [24] . Another candidate is BO-653 (2,3-dihydro-5-hydroxy-2,2-dipentyl-4,6-di-t-butylbenzofuran), which was designed after consideration of many in vitro studies [25] and has shown potent anti-atherogenic effects in all animal model experiments so far [26] . The advantages of BO-653 over vitamin E are that BO-653 is more mobile within LDL particles, spares vitamin E and does not reduce Cu(II). Also, the BO-653-derived radical is less reactive than the vitamin E radical, although the reactivity of BO-653 towards the peroxyl radical is similar to that of vitamin E, and the BO-653 radical is not reduced by vitamin C [27, 28] .
Concluding remarks
Whether antioxidants, above all vitamin E, inhibit atherosclerosis and reduce the risk of coronary heart disease has been the subject of extensive studies, discussion, reviews and debates. The anti-atherogenic effect of vitamin C is also interesting [29] . It has been shown in animal experiments that the antioxidant capacities depend on the species and the regions of artery under consideration [30] . The outcome of human intervention studies may depend on the lifestyle of the subjects, especially diet, exercise, smoking and alcohol drinking. It is quite conceivable that the capacities of antioxidants vary between human subjects and studies.
It is important to recognize that atherosclerosis may proceed by different mechanisms, and it is probably difficult for any antioxidant to be effective for all mechanisms. It is sometimes noted from the results that the administered antioxidant could not inhibit atherosclerosis, although LDL isolated from the same subject was more resistant to oxidation than that from the control, and thus concluded that the antioxidant is not effective and the oxidation hypothesis is doubtful. This is not a rational interpretation. It may be simply because the mechanisms of the oxidation of isolated LDL (often induced by Cu) and atherosclerosis progression were different in this particular case.
Collectively, it may be concluded that the oxidation of LDL, which is undoubtedly pro-atherogenic, proceeds by either a radical mechanism or a non-radical mechanism, and that the radical-scavenging antioxidants such as vitamin E exert beneficial effects on radical-mediated oxidation, but not on non-radical oxidation, such as direct oxidation by lipoxygenase [31] , HOCl and aldehydes. The relative contributions of radical and non-radical mechanisms, which may vary depending on the subject and time, must determine the potency of vitamin E. It may be concluded that the inhibition of LDL oxidation should be effective for prevention of atherosclerosis, and that a combination of antioxidants with different functions is required.
